Glycogen storage disease type I surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Liver transplantation is the final treatment for patients with metabolic disease associated associated with GSD type 1. | |||
==Indications== | ==Indications== | ||
==Surgery== | ==Surgery== |
Revision as of 18:25, 8 November 2017
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I surgery On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I surgery |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Liver transplantation is the final treatment for patients with metabolic disease associated associated with GSD type 1.